Nanoparticles for Targeted Drug Delivery – Researchers are using nanoparticles, including nanoliposomes, to deliver drugs directly to specific sites in the body, reducing harmful side effects and increasing treatment effectiveness.

Preventing Preterm Birth – Scientists at HMRI are developing targeted nanoparticle therapies to stop preterm labor by delivering drugs specifically to the uterus, minimizing risks to both mother and baby.

Improving Ovarian Cancer Treatment – Researchers are working on nanoparticle-based drug delivery systems to enhance treatment precision for ovarian cancer, overcoming challenges like drug filtration by the liver to improve survival rates.